Results for “”

Entry Author Date Location
Cazalot to Lead Techstars Boston, Wants to Energize Local Community 05/03/17 Boston
Pieris Adds Another Partner, Gets $45M in AstraZeneca Lung Drug Deal 05/03/17 Boston
Friend & Flowers Return With Wasabi, Take on Amazon in “Hot Storage” 05/03/17 Boston
Analysis: Trump’s First 100 Days Through the Tech Industry Lens 05/02/17 San Francisco
FDA Wants More Safety Info on Psych Drug, Intra-Cellular Shares Drop 05/01/17 New York
Entrepreneurs, VCs, Bio Builders Talk Seizing Momentum in NY on May 31 05/01/17 New York
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Bio Roundup: Trumpcare Flails, Spinraza Sales, Batten OK & More 04/28/17 National
Gottlieb’s FDA Nomination Gets Committee Nod, Advances to Senate 04/27/17 National
Duchenne, SMA, and the Rise of Patient Power at “What’s Hot” on May 11 04/27/17 Boston
Barclays Techstars’ Jon Zanoff on Startups, Banks, and Fintech’s Future 04/26/17 New York
The Medicines Co., Alnylam Take Plunge, Outline Big Test For Heart Drug 04/26/17 New York
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
Xconomy Bookclub: Big Data Meets Fine Dining in CEO’s “Culinary Tour” 04/24/17 Texas
Becton Dickinson Aims Beyond Diabetes with $24B Bard Deal 04/24/17 New York
Pursuing Larger Rivals, NGM Bio Tries To Make Mark On Fatty Livers 04/22/17 San Francisco
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
After 3-Year Partnership, DePuy Acquires TRS Scaffolding Technology 04/21/17 Detroit Ann Arbor
Request Your Invitation to Xconomy’s Elite Napa Summit June 8-9 04/21/17 National
Insight Partners Buys Data Backup Business Spanning From Dell EMC 04/20/17 Texas
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
“Our Son’s Fate”: Parents Fighting for Kids’ Spine Drug Eye New Data 04/20/17 Boston
Trump Executive Order Adds Uncertainty to Tech Visa Program 04/19/17 Seattle
The Xconomy Roadmap: Top 15 Innovation Areas to Watch (and Disrupt) 04/19/17 National
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Zoetis Builds on Biologics Pipeline with $85M Nexvet Acquisition 04/13/17 New York
On Tap For “What’s Hot” on May 11: Opioid Crisis, Immigration & More 04/13/17 Boston
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Page 2 of 109 « previous page · next page »